Semler Scientific Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Semler Scientific Inc in the third quarter 2025?
Semler Scientific inc achieved a return on average equity (ROE) of 15.65 % in its third quarter 2025, this is above SMLR's average return on equity of 13.63%.
Semler Scientific Inc shareholder's equity over the 12 months ending in its third quarter 2025 are valued at $309 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 21 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 648 to 859.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Equity Change	438.63 %	389.05 %	107.54 %	221.4 %	-
Y / Y Net Income Change	201.34 %	608381.82 %	-	591.92 %	1.72 %
Net Income (TTM) in Millions	48	37	-30	41	16
Return On Equity (TTM)	15.65 %	17.21 %	-21.49 %	34.63 %	20.31 %
SMLR's Total Ranking	# 859	# 648	# 2217	# 219	# 483
Equity (TTM) in Millions	460	383	162	231	85
Seq. Equity Change	19.91 %	137.14 %	-29.93 %	170.34 %	8.87 %
Seq. Net Income Change	-74.75 %	-	-	420.7 %	50890.91 %

Back to SMLR Management Effectiveness >> SMLR's 5 Years Annual ROE >> Compare SMLR ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 22
Sector	# 98
Overall	# 859

Return On Equity Statistics
High	Average	Low
385.69 %	13.63 %	-906.29 %
(Dec 31 2018)		(Dec 31 2015)

SMLR Annual Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021	(Dec 31 2020) 2020
Total Equity in Millions	231	72	56	46	30
Y / Y Equity Change	221.4 %	28.95 %	22.24 %	52.88 %	127.9 %
Net Income in Millions	41	21	14	17	14
Y / Y Net Income Change	98.7 %	43.69 %	-16.82 %	22.95 %	-7.14 %
Return On Equity	17.72 %	28.67 %	25.73 %	37.81 %	47.01 %

Back to SMLR Management Effectiveness >> SMLR's 5 Years Annual ROE >> Compare SMLR ROE to its Competitors

Annual Roe Comment

In 2024 ROE fell to 17.72 %, despite net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SMLR's' Return on Equity at Yahoo Finance
SMLR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SMLR's Competitors
Subscribers only: Roe for Semler Scientific Inc 's Suppliers
Subscribers only: Return On Equity for SMLR's Customers

Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector	ROE
Zevra Therapeutics Inc	42.68 %
Agilent Technologies inc	41.86 %
Gilead Sciences Inc	40.87 %
Entera Bio Ltd	40.47 %
Tenet Healthcare Corp	39.99 %
Merck and Co Inc	38.92 %
Longduoduo Co Ltd	36.66 %
Puma Biotechnology Inc	36.14 %
Sbc Medical Group Holdings Incorporated	35.54 %
Siga Technologies Inc	35.26 %
Bristol myers Squibb Company	34.59 %
Sab Biotherapeutics Inc	33.39 %
Johnson and Johnson	32.69 %
Acadia Pharmaceuticals Inc	32.27 %
Lifevantage Corp	31.72 %
Transmedics Group Inc	31.42 %
Waters Corporation	31.23 %
Synlogic Inc	31.15 %
Pro dex Inc	31.03 %
Illumina Inc	29.94 %
Incyte Corporation	29.83 %
Dexcom Inc	29.82 %
Rafael Holdings Inc	28.73 %
Abbott Laboratories	28.09 %
Oramed Pharmaceuticals Inc	27.36 %
Prestige Consumer Healthcare Inc	27.10 %
Catalyst Pharmaceuticals Inc	26.39 %
Pacs Group Inc	26.36 %
Solventum Corporation	25.88 %
Resmed Inc	25.56 %

Date modified: 2026-09-08T22:21:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.